375 related articles for article (PubMed ID: 9738588)
1. Tumor-suppressor p53: implications for tumor development and prognosis.
Kirsch DG; Kastan MB
J Clin Oncol; 1998 Sep; 16(9):3158-68. PubMed ID: 9738588
[TBL] [Abstract][Full Text] [Related]
2. Prognostic and predictive significance of p53 mutation in aggressive B-cell lymphoma.
Ichikawa A
Int J Hematol; 2000 Apr; 71(3):211-20. PubMed ID: 10846825
[TBL] [Abstract][Full Text] [Related]
3. [Tumor suppressor gene p53: mechanisms of action in cell proliferation and death].
Mendoza-Rodríguez CA; Cerbón MA
Rev Invest Clin; 2001; 53(3):266-73. PubMed ID: 11496714
[TBL] [Abstract][Full Text] [Related]
4. The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer.
Smith ND; Rubenstein JN; Eggener SE; Kozlowski JM
J Urol; 2003 Apr; 169(4):1219-28. PubMed ID: 12629332
[TBL] [Abstract][Full Text] [Related]
5. Tumor suppressor p53: regulation and function.
Somasundaram K
Front Biosci; 2000 Apr; 5():D424-37. PubMed ID: 10762600
[TBL] [Abstract][Full Text] [Related]
6. Biological and clinical importance of the p53 tumor suppressor gene.
Velculescu VE; El-Deiry WS
Clin Chem; 1996 Jun; 42(6 Pt 1):858-68. PubMed ID: 8665676
[TBL] [Abstract][Full Text] [Related]
7. p53 mutation heterogeneity in cancer.
Soussi T; Lozano G
Biochem Biophys Res Commun; 2005 Jun; 331(3):834-42. PubMed ID: 15865939
[TBL] [Abstract][Full Text] [Related]
8. [TP53 mutations and molecular epidemiology].
Otsuka K; Ishioka C
Gan To Kagaku Ryoho; 2007 May; 34(5):683-9. PubMed ID: 17496437
[TBL] [Abstract][Full Text] [Related]
9. Living with p53, dying of p53.
Aylon Y; Oren M
Cell; 2007 Aug; 130(4):597-600. PubMed ID: 17719538
[TBL] [Abstract][Full Text] [Related]
10. p53: Protection against Tumor Growth beyond Effects on Cell Cycle and Apoptosis.
Wang X; Simpson ER; Brown KA
Cancer Res; 2015 Dec; 75(23):5001-7. PubMed ID: 26573797
[TBL] [Abstract][Full Text] [Related]
11. [An overview of research on p53 tumor suppressor gene].
Yokozaki H; Tahara E
Gan To Kagaku Ryoho; 1997 Dec; 24(15):2181-6. PubMed ID: 9422058
[TBL] [Abstract][Full Text] [Related]
12. Clinical implications of p53: effect on prognosis, tumor progression and chemotherapy response.
Peller S
Semin Cancer Biol; 1998; 8(5):379-87. PubMed ID: 10101803
[TBL] [Abstract][Full Text] [Related]
13. P53, cell cycle control and apoptosis: implications for cancer.
Kastan MB; Canman CE; Leonard CJ
Cancer Metastasis Rev; 1995 Mar; 14(1):3-15. PubMed ID: 7606818
[TBL] [Abstract][Full Text] [Related]
14. Induction of genetic instability by gain-of-function p53 cancer mutants.
Xu Y
Oncogene; 2008 Jun; 27(25):3501-7. PubMed ID: 18223686
[TBL] [Abstract][Full Text] [Related]
15. [p53 as a molecular target for cancer therapy].
Ishioka C; Osada M; Gamo M; Kanamaru R
Gan To Kagaku Ryoho; 1997 Dec; 24(15):2207-12. PubMed ID: 9422063
[TBL] [Abstract][Full Text] [Related]
16. The dual role of mutant p53 protein in chemosensitivity of human cancers.
Mueller H; Eppenberger U
Anticancer Res; 1996; 16(6B):3845-8. PubMed ID: 9042268
[TBL] [Abstract][Full Text] [Related]
17. Mouse models dissect the role of p53 in cancer and development.
Lozano G; Liu G
Semin Cancer Biol; 1998; 8(5):337-44. PubMed ID: 10101799
[TBL] [Abstract][Full Text] [Related]
18. The genetics of the p53 pathway, apoptosis and cancer therapy.
Vazquez A; Bond EE; Levine AJ; Bond GL
Nat Rev Drug Discov; 2008 Dec; 7(12):979-87. PubMed ID: 19043449
[TBL] [Abstract][Full Text] [Related]
19. The p53 tumour suppressor protein.
Hickman ES; Helin K
Biotechnol Genet Eng Rev; 2000; 17():179-211. PubMed ID: 11255666
[No Abstract] [Full Text] [Related]
20. Wild-type p53 in cancer cells: when a guardian turns into a blackguard.
Kim E; Giese A; Deppert W
Biochem Pharmacol; 2009 Jan; 77(1):11-20. PubMed ID: 18812169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
